Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

China Health Industries Holdings, Inc. (CHHE) EBIT Margin (2017 - 2024)

China Health Industries Holdings (CHHE) has disclosed EBIT Margin for 13 consecutive years, with 163512.64% as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, EBIT Margin fell 16197424.0% year-over-year to 163512.64%, compared with a TTM value of 391.27% through Mar 2024, up 73505.0%, and an annual FY2023 reading of 76.93%, up 2753131.0% over the prior year.
  • EBIT Margin was 163512.64% for Q1 2024 at China Health Industries Holdings, up from 968597.83% in the prior quarter.
  • Across five years, EBIT Margin topped out at 1994.64% in Q2 2023 and bottomed at 47566100.0% in Q2 2022.
  • Average EBIT Margin over 5 years is 5534610.67%, with a median of 1423.09% recorded in 2022.
  • The sharpest move saw EBIT Margin tumbled 2000000000bps in 2022, then soared 2000000000bps in 2023.
  • Year by year, EBIT Margin stood at 36.45% in 2020, then plummeted by -37396260bps to 13630350.0% in 2021, then skyrocketed by 100bps to 1585.01% in 2022, then plummeted by -61010bps to 968597.83% in 2023, then surged by 83bps to 163512.64% in 2024.
  • Business Quant data shows EBIT Margin for CHHE at 163512.64% in Q1 2024, 968597.83% in Q4 2023, and 480.31% in Q3 2023.